Vazyme's subsidiary products have obtained medical device registration certificates
I'm PortAI, I can summarize articles.
Vazyme's wholly-owned subsidiary, Nanjing Vazyme Medical Technology Co., Ltd., recently obtained multiple medical device registration certificates, involving a series of diagnostic reagent products for the nervous system. The company relies on its antibody technology platform to continuously enrich its AD blood test series products and innovatively develop precise detection products for Parkinson's disease and brain injuries, aiming to meet clinical needs in the field of neurological diseases and enhance the diagnosis and treatment service level for brain health and cognitive disorders
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments